HTFL

アフターアワーズ： 34.71

Heartflow Inc (HTFL)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Heartflow Inc Stock (HTFL) Company Profile

Heartflow Inc

Healthcare (1131)

650-241-1221

331 E EVELYN AVENUE, MOUNTAIN VIEW

HTFL's Discussions on Twitter

HTFL を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
HTFL Heartflow Inc	34.71	2.83B	0	0	0	0.00
VEEV Veeva Systems Inc	295.26	48.11B	2.97B	809.93M	1.33B	4.8743
TEM Tempus Ai Inc	82.26	14.68B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	63.99	12.33B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	94.39	8.19B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	36.75	7.17B	906.14M	-52.62M	89.62M	-0.3621

Heartflow Inc Stock (HTFL) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2025-09-02	開始されました	Canaccord Genuity	Buy
2025-09-02	開始されました	JP Morgan	Overweight
2025-09-02	開始されました	Morgan Stanley	Equal-Weight
2025-09-02	開始されました	Piper Sandler	Overweight
2025-09-02	開始されました	Stifel	Buy

Heartflow Inc (HTFL) 最新ニュース

Heartflow Inc (HTFL) 財務データ

Heartflow Inc (HTFL) の財務データはありません。詳細については、他の銘柄を確認してください。

Heartflow Inc (HTFL)

Heartflow Inc Stock (HTFL) Company Profile

HTFL を他の銘柄と比較する

Heartflow Inc Stock (HTFL) Upgrades & Downgrades

Heartflow Inc (HTFL) 最新ニュース

Heartflow (NASDAQ:HTFL) Coverage Initiated at Weiss Ratings - MarketBeat

Strong Investor Reception of IPO Boosted Heartflow (HTFL) in Q3 - Insider Monkey

Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025 - MarketScreener

Heartflow (NASDAQ: HTFL) to present late-breaking Plaque Analysis AHA 2025: 7 abstracts - Stock Titan

Heartflow, Inc. (NASDAQ:HTFL) Sees Significant Decline in Short Interest - MarketBeat

HeartFlow’s Innovative Study on Cardiac Risk in NFL Alumni: A Potential Game-Changer - TipRanks

HeartFlow’s COMPLETE Study: A New Frontier in Coronary Artery Disease Evaluation - TipRanks

FDA Clears Next-Gen Heartflow Plaque Analysis Platform - Medical Product Outsourcing

Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025 - The Manila Times

Heartflow (NASDAQ:HTFL) Trading 5.5% HigherWhat's Next? - MarketBeat

Heartflow Introduces PCI Planning Tool - Diagnostic and Interventional Cardiology

Assessing HeartFlow After a 14% Weekly Surge and Expanding Tech Partnerships - Yahoo Finance

Heartflow (NASDAQ:HTFL) Sets New 52-Week HighShould You Buy? - MarketBeat

Heartflow introduces Heartflow PCI Navigator - TipRanks

New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning - The Manila Times

Heartflow (NASDAQ: HTFL) unveils PCI Navigator for 3D planning; NAVIGATE-PCI enroll 2,500 - Stock Titan

Heartflow, Inc. (NASDAQ:HTFL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Technical Analysis of Heartflow, Inc. (NASDAQ:HTFL) - TradingView

ETFs Investing in Heartflow, Inc. Stocks - TradingView

HTFL Stock Price and Chart — NASDAQ:HTFL - TradingView

Heartflow (NASDAQ:HTFL) Sets New 12-Month HighShould You Buy? - MarketBeat

HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis - Yahoo Finance

Heartflow, Inc. (NASDAQ:HTFL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Why HeartFlow Stock Rocketed 14% Higher Today - MSN

Heartflow receives FDA clearance for updated plaque analysis platform - MedTech Dive

Cigna will cover CT imaging artificial intelligence software nationwide - Radiology Business

HTFL Crosses Above Average Analyst Target - Nasdaq

FDA clears Heartflow’s next-gen plaque analysis - BioWorld MedTech

Heartflow (NASDAQ:HTFL) Shares Up 10% Following Analyst Upgrade - MarketBeat

CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $39 - 富途牛牛

Heartflow secures FDA clearance for updated plaque analysis platform - Yahoo Finance

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform - BioSpace

Heartflow (NASDAQ:HTFL) Given New $39.00 Price Target at Canaccord Genuity Group - Defense World

FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it - Investing.com

FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it By Investing.com - Investing.com South Africa

Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis By Investing.com - Investing.com Nigeria

Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis - Investing.com Nigeria

Heartflow announces FDA 510(k) clearance and launch of next generation Heartflow Plaque Analysis platform - MarketScreener

Heartflow Announces FDA 510(K) Clearance And Launch Of Next Generation Heartflow Plaque Analysis Platform - TradingView

Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform - MarketScreener

Cigna (CI) to Cover Heartflow's Newly Approved Technology - GuruFocus

FDA Clears Heartflow Coronary Plaque Technology - MarketScreener

Heartflow announces FDA clearance of plaque analysis algorithm, Cigna coverage - TipRanks

95% Accuracy vs Gold Standard: HeartFlow's Revolutionary AI Heart Disease Platform Wins FDA Approval - Stock Titan

Heartflow (NASDAQ:HTFL) Stock Price Down 5.2% After Earnings Miss - MarketBeat

Canaccord Genuity raises Heartflow stock price target to $39 on FFRct growth - Investing.com Nigeria

Canaccord Genuity Group Issues Positive Forecast for Heartflow (NASDAQ:HTFL) Stock Price - MarketBeat

Heartflow price target raised to $39 from $35 at Canaccord - TipRanks

Heartflow (NASDAQ:HTFL) Announces Quarterly Earnings Results - MarketBeat

Heartflow Inc (HTFL) 財務データ

収益

当期純利益

現金流量

EPS

HTFLに似た銘柄